Mindset Pharma Files a Sixth U.S. Provisional Patent, Further Expanding Its Psychedelic Drug Candidates Pipeline With Novel DMT & 5-MeO-DMT Analogs

CANNANNEW REPORT

Toronto, Ontario–(Newsfile Corp. – March 15, 2021) –  Mindset Pharma Inc. (CSE:MSET) (FSE: 9DF) (“Mindset” or the “Company“) is pleased… Read More….. The post Mindset Pharma Files a Sixth U.S. Provisional Patent, Further Expanding Its Psychedelic Drug Candidates Pipeline With Novel DMT & 5-MeO-DMT Analogs appeared first on Cannabis Law Report.

Excerpt only …
READ MORE BELOW
Source : Mindset Pharma Files a Sixth U.S. Provisional Patent, Further Expanding Its Psychedelic Drug Candidates Pipeline With Novel DMT & 5-MeO-DMT Analogs

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.